TL;DR
Major US health insurers are accelerating their strategic retreat from volatile, government-sponsored programs, shifting their focus from underwriting margins to their unregulated, vertically integrated service segments. While companies absorb near-term pain from Medicaid and Medicare Advantage contractions, internal service engines like Optum and Carelon are driving consolidated profit recovery. Simultaneously, federal courts are reinforcing the industry's legal defenses, utilizing preemption shields to protect integrated pharmacy benefit manager (PBM) structures from state-level attacks.
The Flight from Government Risk to Vertical Services
Managed care giants are aggressively dialing back their exposure to volatile government-sponsored programs, shifting their strategic focus toward capturing unregulated margins through internal healthcare service arms.
"Medicaid participation has to make strategic and financial sense for us within our diversified portfolio. Where those conditions aren't present, we're going to take the disciplined action that we need to." — Elevance Health: Carelon and the Internal Profit Engine
"We now expect full-year Medicare Advantage enrollment to decline by approximately 1.1 million and Medicare margins to finish 2026 above 3%." — UnitedHealth and Optum Vertical Integration
This margin-over-volume trade-off shows that top-tier insurers are no longer willing to absorb public-sector losses. Instead of chasing enrollment in highly regulated lines where gross underwriting margins are strictly capped by federal Medical Loss Ratio (MLR) rules, companies are routing capital into unregulated segments like Carelon and Optum The Managed Care Profit Engine. This internal redirection allows conglomerates to capture multiple margin points across the healthcare delivery chain, shifting profits away from insurance restrictions and into clinical, technology, and specialty pharmacy services The Managed Care Profit Engine
.
What to watch: Watch for whether Elevance's planned exits from additional state Medicaid markets over the next 12 to 18 months trigger a broader, industry-wide retrenchment from government-sponsored risk Elevance Health: Carelon and the Internal Profit Engine.
The Federal Judicial Shield for PBM Integration
Even as states design increasingly sophisticated legislation to restrict vertical pharmacy benefit manager ownership, national insurers are successfully shielding their integrated profit centers using federal preemption.
"requir[e] PBMs to tailor and retailor their networks — and perhaps even build new brick-and-mortar pharmacies — to comply with a set of exacting particularities." — PBM Vertical Integration
, citing Kevin Flowers v. Caremark PCS Health, LLC, No. 25-3068
This legal barrier demonstrates that the federal judiciary remains a formidable line of defense for the managed care industry. By relying on ERISA preemption to invalidate state geographic pharmacy network rules, courts are preventing local regulators from disrupting uniform, national PBM operations PBM Vertical Integration. This federal protection ensures that conglomerates like CVS Health, Cigna, and UnitedHealth can continue to execute highly profitable intersegment transactions between their owned PBMs, specialty pharmacies, and insurance plans without state-by-state interference The Managed Care Profit Engine
.
What to watch: Watch for the federal district court's decision on the lawsuits filed by CVS Caremark, Cigna's Express Scripts, and the PCMA challenging Tennessee's newly enacted Fair RX Act PBM Vertical Integration.
What surprised us
- Optum Health's provider profits nearly tripled despite serving fewer patients. UnitedHealth's clinical provider segment saw its operating profits surge 177.4% year-over-year to $1.19 billion UnitedHealth and Optum Vertical Integration
. This massive bottom-line expansion, occurring even as the unit served fewer value-based care patients, proves that the real money in managed care has decoupled from raw membership growth and now relies on back-end clinical cost management and consumer services.
- Elevance chose to hide a major earnings beat inside its service segment. Rather than letting a one-time, below-the-line benefit of $0.80 per share drop directly to its bottom line, Elevance's management chose to plow those funds straight back into Carelon's technology and clinical capabilities Elevance Health: Carelon and the Internal Profit Engine
- UnitedHealth's massive prior authorization cut is a strategic pivot, not a retreat. In response to public and political outrage, UnitedHealth announced plans to eliminate 30% of its total prior authorization volumes by the end of 2026 UnitedHealth and Optum Vertical Integration
.